tongue cancer Genome/Transcriptome Sequencing Project Promises PGx Strategy for Rare Cancers Premium A recent study combined analysis of a patient's tumor genome and transcriptome sequences to guide treatment of tongue adenocarcinoma with Pfizer's Sutent (sunitinib) and Bayer's Nexavar (sorafenib). Breaking News Cancer Diagnostics Firm Syantra Raises $3.6M in Series A-1 Round GenomOncology, Precipio Partner on Myeloid Test Reporting Pillar Biosciences, AstraZeneca Partner on Liquid Biopsy Testing in Europe Oxford Nanopore Technologies to Sue BGI Group Affiliates for Contract Breach Viome Life Sciences Raises $25M in Series D Financing
